- Biotechnology
- Thursday, 01 Apr 2021
Europe Drug Modelling Software Market Volume Analysis, Segments, Value Share and Key Trends 2020-2027
According to our new market research study on “Europe Drug Modelling Software Market to 2027 – Regional Analysis and Forecast – by Type, and Application” the market is expected to reach US$ 3,215.94 million by 2027 from US$ 1,826.99 million in 2019; it is estimated to grow at a CAGR of 7.6% from 2020 to 2027. The report provides trends prevailing in the Europe drug modelling software market and the factors driving the market growth along with those hindering it.
In 2019, the software segment accounted for the highest share of the market. Also, the same segment is estimated to grow at the highest CAGR in the forecast period. Growth of this segment is attributed to the growing demand for effective therapeutics and increase in drug discovery efforts of various biologics across a wide range of therapeutics. In addition, strategic activities by service providers such as collaborations, product advancement, and product launch in order to expediate drug discovery timeline are further accelerating the growth of the market.
Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.theinsightpartners.com/sample/TIPRE00013989/
Company Profiles
- Crown Bioscience Inc (JSR life science)
- Genedata AG
- Biognos AB
- Dassault Systèmes
- Acellera
The growth of the Europe drug modelling software market is mainly attributed to the rapid integration of AI for the drug discovery, increasing preference for personalized medicine, high R&D spending for novel therapeutic applications and presence of major market players. However, the lack of data standardization is the major factor hindering the market growth in Europe.
Genedata AG; Biognos AB; Dassault Systèmes; Acellera; and Crown Bioscience Inc (JSR life science) are among the leading companies operating in the Europe drug modelling software market.
EUROPE DRUG MODELLING SOFTWARE MARKET SEGMENTATION
By Product Type
- Database
- Software
- Others
By Application
- Drug Discovery and Development
- Computational Physiological Medicine
- Disease Modeling
- Medical Imaging
- Predictive Analysis of Drug Targets
- Simulation Software
- Cellular Simulation
- Others
By Country
- Germany
- France
- United Kingdom
- Italy
- Spain
Purchase a copy of this research report @ https://www.theinsightpartners.com/buy/TIPRE00013989/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Related Industry Updates
Europe Cancer Vaccines Market 2027 In-Depth Coverage and Various Important Aspects of Covid 19 Outbreak Impact with top keyplayer like AstraZeneca,GlaxoSmithKline plc.,Aduro Biotech Inc,Pfizer Inc.,Sanofi
Mar 19, 2021
Cancer Vaccines Market To Surge in The Near Future with Rapid Revenue Growth Across Key Industries
Sep 18, 2020
Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma
May 05, 2020
Asia Pacific Next Generation Sequencing Market is expected to reach US$ 5,835.6 Million by 2027 with CAGR of 21.8%.
Oct 06, 2020
T Cell Therapy Market is expected to reach US$ 9,035.01 million by 2030
Sep 14, 2023
Biopharmaceuticals Contract Manufacturing Market Higher Growth Rate and Forecast 2021–2027 | Key Companies: AbbVie Inc. , WuXi Biologics , General Electric , Samsung Biologics , Merck KGaA , Ajinomoto Co., Inc, etc
May 03, 2021
Whole Exome Sequencing Industry 2021 Manufacturers Strategy with Growth Rate, Share, Market Size, Gross Margin, Progression Status and Forecast to 2027
Feb 15, 2021